##{"id":97089,"date":"2021-10-08T16:51:00","date_gmt":"2021-10-08T05:51:00","guid":{"rendered":"https:\/\/www.fnarena.com\/index.php\/2021\/10\/08\/viraleze-antiviral-nasal-spray-launched-in-admenta-italia-group-pharmacies-in-italy\/"},"modified":"2021-10-08T16:51:00","modified_gmt":"2021-10-08T05:51:00","slug":"viraleze-antiviral-nasal-spray-launched-in-admenta-italia-group-pharmacies-in-italy","status":"publish","type":"post","link":"https:\/\/staging.fnarena.com\/index.php\/2021\/10\/08\/viraleze-antiviral-nasal-spray-launched-in-admenta-italia-group-pharmacies-in-italy\/","title":{"rendered":"VIRALEZE\u2122 antiviral nasal spray launched in ADMENTA Italia Group pharmacies in Italy"},"content":{"rendered":"<p><span class=\"xn-location\">MELBOURNE, Australia<\/span>, <span class=\"xn-chron\">Oct. 8, 2021<\/span> \/PRNewswire\/ &#8211;&#160;Australian biotech company Starpharma today announced it has signed a sales and distribution agreement for its VIRALEZE\u2122 antiviral nasal spray with ADMENTA Italia Group (ADMENTA), a leading pharmaceutical retail and wholesale distribution company in <span class=\"xn-location\">Italy<\/span>. The Italian over-the-counter pharmaceutical&#160;market is the third largest in <span class=\"xn-location\">Europe<\/span> after <span class=\"xn-location\">Germany<\/span> and the UK.<\/p>\n<p>VIRALEZE\u2122 is expected to be available to Italian consumers this quarter through ADMENTA&#8217;s extensive LloydsFarmacia chain, which comprises 260 retail pharmacies, including 13 parapharmacies and 50 franchising pharmacies, as well as LloydsFarmacia&#8217;s <a target=\"_blank\" href=\"https:\/\/www.lloydsfarmacia.it\/\" rel=\"nofollow\">online<\/a>&#160;platform.&#160;<\/p>\n<p>VIRALEZE\u2122 is a broad-spectrum antiviral nasal spray, applied in the nose to provide a physical barrier \u2013 between viruses and the nasal mucous membrane&#160;\u2013 which traps and irreversibly inactivates viruses, including SARS-CoV-2. Its antiviral agent, SPL7013, has been shown in laboratory studies to have potent antiviral and virucidal activity in multiple respiratory viruses, including multiple variants of SARS-CoV-2, where it has been shown to inactivate &#062;99.9% of the highly infectious <a target=\"_blank\" href=\"https:\/\/starpharma.com\/news\/609\" rel=\"nofollow\">Delta variant<\/a>.<\/p>\n<p>ADMENTA employs 1,400 people in <span class=\"xn-location\">Italy<\/span> across its wholesale and retail operations, supplying more than 2,500 pharmacies, parapharmacies, drug stores and hospitals.&#160;<\/p>\n<p>ADMENTA is also the Italian holding company of <span class=\"xn-person\">McKesson Europe<\/span>. The US-based McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology.<\/p>\n<p><span class=\"xn-person\">Vincenzo Masci<\/span>, Marketing and Procurement Director of ADMENTA-LloydsFarmacia, said: &#034;We are delighted to have partnered with Starpharma for VIRALEZE\u2122 antiviral nasal spray in <span class=\"xn-location\">Italy<\/span>. VIRALEZE\u2122 will be an excellent addition to both our retail and distribution sectors as we head towards winter.&#034;&#160;<\/p>\n<p>Dr <span class=\"xn-person\">Jackie Fairley<\/span>, CEO of Starpharma, said: &#034;We are very pleased to have partnered with ADMENTA in <span class=\"xn-location\">Italy<\/span> and we look forward to having VIRALEZE\u2122 available soon to Italian consumers, through pharmacies as well as through the leading LloydsFarmacia online platform.&#034;<\/p>\n<p>VIRALEZE\u2122 antiviral nasal spray is registered in <span class=\"xn-location\">Europe<\/span> and <span class=\"xn-location\">India<\/span>, and available in certain markets online at <a target=\"_blank\" href=\"http:\/\/www.viraleze.co\/\" rel=\"nofollow\">www.viraleze.co<\/a>.&#160;In the UK, VIRALEZE\u2122 is partnered with LloydsPharmacy, also part of the McKesson group, and Starpharma is in advanced discussions with potential commercial partners elsewhere in <span class=\"xn-location\">Europe<\/span>, <span class=\"xn-location\">India<\/span>, <span class=\"xn-location\">Asia<\/span> and other regions. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>MELBOURNE, Australia, Oct. 8, 2021 \/PRNewswire\/ &#8211;&#160;Australian biotech company Starpharma today announced it has signed a sales and distribution agreement&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[105],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts\/97089"}],"collection":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/comments?post=97089"}],"version-history":[{"count":0,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts\/97089\/revisions"}],"wp:attachment":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/media?parent=97089"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/categories?post=97089"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/tags?post=97089"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}